Regional Variance of the Early Use of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease.

Inoue, Reiko; Nishi, Hiroshi; Inoue, Daisuke; Honda, Kenjiro; Nangaku, Masaomi

Inoue, Reiko; Nishi, Hiroshi; Inoue, Daisuke; Honda, Kenjiro; Nangaku, Masaomi.

Afiliação

Inoue R; Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.
Nishi H; Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.
Inoue D; Division of Nephrology, Department of Medicine, Mitsui Memorial Hospital, Tokyo, Japan.
Honda K; Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.
Nangaku M; Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.

Kidney360 ; 1(8): 740-745, 2020 08 27.

Article em En | MEDLINE | ID: mdl-35372950

Assuntos

Hiponatremia; Rim Policístico Autossômico Dominante; Antagonistas dos Receptores de Hormônios Antidiuréticos/uso terapêutico; Ascite/tratamento farmacológico; Humanos; Hiponatremia/tratamento farmacológico; Rim Policístico Autossômico Dominante/tratamento farmacológico; Tolvaptan/uso terapêutico

Palavras-chave

Japan; autosomal dominant; cystic kidney disease; polycystic kidney; population density; regional variance; tolvaptan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Hiponatremia Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google